Myovant Sciences Ltd Share | Buy US Stock from India on Kuvera

Q: Can I buy Myovant Sciences Ltd shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Myovant Sciences Ltd stocks after a simple registration process. </div>

Q: How to buy Myovant Sciences Ltd shares in India?

<div> To buy Myovant Sciences Ltd shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Myovant Sciences Ltd and you are done!</div> </div>

Q: What is the share price of Myovant Sciences Ltd?

<div>The share price of Myovant Sciences Ltd is USD 26.99 as on 9 Mar.</div>

Q: What is the Market Capitalization of Myovant Sciences Ltd?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Myovant Sciences Ltd is USD 2.62B as on 9 Mar.</div>

Q: What is the PE ratio of Myovant Sciences Ltd?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Myovant Sciences Ltd is N/A as on 9 Mar. </div>

Q: Is Myovant Sciences Ltd a good stock to buy?

<div>Kuvera provides relevant fundamental details of Myovant Sciences Ltd to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Myovant Sciences Ltd operate?

<div> Myovant Sciences Ltd operates in Healthcare / Biotechnology

Healthcare Biotechnology

$26.99

(9 Mar)

Loading Chart

Previous close

$26.99

Open

$26.99

Today’s high

$27.00

Today’s low

$26.98

52W low

$7.67

52W high

$27.06

0.04%

11.65%

Shares O/S

97.24M

Market cap

2.62B

Insights

MYOV has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

MYOV price is above its 200 day moving average

In beta. Send feedback here.

Compare with other stock

About Myovant Sciences Ltd

Myovant Sciences Ltd is a biopharmaceutical company. The Company is focused on redefining care for women and for men through science, medicines and transformative advocacy. The Company’s two products include ORGOVYX (relugolix 120 mg), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer; and MYFEMBREE, a once-daily oral treatment for the management of heavy menstrual bleeding associated with uterine fibroids.

The Company, through its subsidiary, Myovant Sciences GmbH develops supplemental New Drug Application for once-daily MYFEMBREE for the management of moderate to severe pain associated with endometriosis and being assessed for contraceptive efficacy in women ages 18-35 years who are at risk for pregnancy. It develops Relugolix for the treatment of men with advanced prostate cancer. The Company is also developing MVT-602, which has completed a Phase IIa study for the treatment of female infertility. .

FAQs

Can I buy Myovant Sciences Ltd shares in India?

How to buy Myovant Sciences Ltd shares in India?

What is the share price of Myovant Sciences Ltd?

What is the Market Capitalization of Myovant Sciences Ltd?

What is the PE ratio of Myovant Sciences Ltd?

Is Myovant Sciences Ltd a good stock to buy?

In which sector / industry does Myovant Sciences Ltd operate?